share_log

HC Wainwright & Co. Maintains Buy on Tango Therapeutics, Raises Price Target to $16

Benzinga ·  Aug 11, 2023 06:49

HC Wainwright & Co. analyst Robert Burns maintains Tango Therapeutics (NASDAQ:TNGX) with a Buy and raises the price target from $11 to $16.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment